ArticleOncoscience2015
MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments.
Mariska Miranda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ArticleOncoscience2015
Mariska Miranda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.